Patents by Inventor Richard Roger Spaete

Richard Roger Spaete has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treatment and prevention of HSV-2 infections and conditions
    Patent number: 7592169
    Abstract: Live, attenuated, phenotypically stable HSV-2 viruses and methods of making and using the virus are provided. Live, attenuated HSV-2 viruses are constructed using recombinant techniques and can be used in a pharmaceutical composition for prophylactic treatment of HSV-2 infections and for treatment of recurrent HSV-2 related diseases and conditions.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: September 22, 2009
    Assignee: MedImmune, LLC
    Inventors: Richard Roger Spaete, George Kemble, Bernard Roizman, Mark Prichard
  • Human cytomegalovirus DNA sequences
    Patent number: 7208165
    Abstract: Provided are novel Toledo and Towne human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for Preventing HCMV infections.
    Type: Grant
    Filed: December 5, 2005
    Date of Patent: April 24, 2007
    Assignee: MedImmune Vaccines, Inc.
    Inventors: Richard Roger Spaete, Tai-An Cha